Posts mit dem Label Immune Response werden angezeigt. Alle Posts anzeigen
Posts mit dem Label Immune Response werden angezeigt. Alle Posts anzeigen

Donnerstag, Juni 10, 2021

The BNT162b2 mRNA vaccine against SARS-CoV-2 reprograms both adaptive and innate immune response

The mRNA-based BNT162b2 vaccine from Pfizer/BioNTech was the first registered COVID-19 vaccine and has been shown to be up to 95% effective in preventing SARS-CoV-2 infections. Little is known about the broad effects of the new class of mRNA vaccines, especially whether they have combined effects on innate and adaptive immune responses. mehr...